BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 25643325)

  • 1. A genome-wide association study of myasthenia gravis.
    Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
    JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
    Chia R; Saez-Atienzar S; Murphy N; Chiò A; Blauwendraat C; ; Roda RH; Tienari PJ; Kaminski HJ; Ricciardi R; Guida M; De Rosa A; Petrucci L; Evoli A; Provenzano C; Drachman DB; Traynor BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35074870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQA1*03:02/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese.
    Zhu WH; Lu JH; Lin J; Xi JY; Lu J; Luo SS; Qiao K; Xiao BG; Lu CZ; Zhao CB
    J Neuroimmunol; 2012 Jun; 247(1-2):81-5. PubMed ID: 22503410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of the HLA-DQ alleles with myasthenia gravis in Cuban patients.
    Sylvia T; Samuel M; Luis G; Zuzet M
    Hum Immunol; 2013 Aug; 74(8):983-5. PubMed ID: 23628390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients.
    Yang H; Hao J; Peng X; Simard AR; Zhang M; Xie Y; Wang S
    J Neurol Sci; 2012 Jan; 312(1-2):57-61. PubMed ID: 21917268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Insights into Myasthenia Gravis Identify Distinct Immunological Mechanisms in Early and Late Onset Disease.
    Handunnetthi L; Knezevic B; Kasela S; Burnham KL; Milani L; Irani SR; Fang H; Knight JC
    Ann Neurol; 2021 Sep; 90(3):455-463. PubMed ID: 34279044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.
    Saruhan-Direskeneli G; Hughes T; Yilmaz V; Durmus H; Adler A; Alahgholi-Hajibehzad M; Aysal F; Yentür SP; Akalin MA; Dogan O; Marx A; Gülsen-Parman Y; Oflazer P; Deymeer F; Sawalha AH
    Clin Immunol; 2016 May; 166-167():81-8. PubMed ID: 27181991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.
    Ehsan S; Amirzargar A; Yekaninejad MS; Mahmoudi M; Mehravar S; Moradi B; Nafissi S
    J Neurol Sci; 2015 Dec; 359(1-2):335-42. PubMed ID: 26671138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States.
    Deitiker PR; Oshima M; Smith RG; Mosier D; Atassi MZ
    Int J Immunogenet; 2011 Feb; 38(1):55-62. PubMed ID: 21108743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
    Gregersen PK; Kosoy R; Lee AT; Lamb J; Sussman J; McKee D; Simpfendorfer KR; Pirskanen-Matell R; Piehl F; Pan-Hammarstrom Q; Verschuuren JJ; Titulaer MJ; Niks EH; Marx A; Ströbel P; Tackenberg B; Pütz M; Maniaol A; Elsais A; Tallaksen C; Harbo HF; Lie BA; Raychaudhuri S; de Bakker PI; Melms A; Garchon HJ; Willcox N; Hammarstrom L; Seldin MF
    Ann Neurol; 2012 Dec; 72(6):927-35. PubMed ID: 23055271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of
    Seldin MF; Alkhairy OK; Lee AT; Lamb JA; Sussman J; Pirskanen-Matell R; Piehl F; Verschuuren JJGM; Kostera-Pruszczyk A; Szczudlik P; McKee D; Maniaol AH; Harbo HF; Lie BA; Melms A; Garchon HJ; Willcox N; Gregersen PK; Hammarstrom L
    Mol Med; 2016 Mar; 21(1):769-781. PubMed ID: 26562150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the genetics of autoimmune myasthenia gravis: an evolving story.
    Lisak RP; Barcellos L
    JAMA Neurol; 2015 Apr; 72(4):386-7. PubMed ID: 25643244
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis.
    Varade J; Wang N; Lim CK; Zhang T; Zhang Y; Liu X; Piehl F; Matell R; Cao H; Xu X; Hammarström L
    J Autoimmun; 2018 Mar; 88():43-49. PubMed ID: 29037440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
    Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
    J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.
    Sun L; Meng Y; Xie Y; Zhang H; Zhang Z; Wang X; Jiang B; Li W; Li Y; Yang Z
    PLoS One; 2014; 9(7):e101986. PubMed ID: 25003519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.
    Li F; Yuan W; Wu X
    Ann Hum Genet; 2018 Nov; 82(6):358-369. PubMed ID: 30009380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.
    Topaloudi A; Zagoriti Z; Flint AC; Martinez MB; Yang Z; Tsetsos F; Christou YP; Lagoumintzis G; Yannaki E; Zamba-Papanicolaou E; Tzartos J; Tsekmekidou X; Kotsa K; Maltezos E; Papanas N; Papazoglou D; Passadakis P; Roumeliotis A; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Yovos J; Stamatoyannopoulos J; Poulas K; Kleopa K; Tzartos S; Georgitsi M; Paschou P
    J Med Genet; 2022 Aug; 59(8):801-809. PubMed ID: 34400559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of susceptibility loci for cervical cancer.
    Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
    J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.
    Li HF; Hong Y; Zhang X; Xie Y; Skeie GO; Hao HJ; Gilhus NE; Liang B; Yue YX; Zhang XJ; Gao X; Wang Q; Gao Z; Ding XJ; Song M
    Mol Neurobiol; 2017 Aug; 54(6):4771-4780. PubMed ID: 27501803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.